News
2don MSN
Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...
2d
MedPage Today on MSNPulmonary Rehabilitation for COPD Pushes Forward"The science shows that there is greater benefit from pulmonary rehab than any pharmacology we can give a COPD patient, so a ...
People with COPD are vulnerable to small increases in PM2.5, with each 1 μg/m3 rise in long-term exposure linked to a 3.8% ...
Canadian wildfire smoke has entered the Upper Midwest and poses significant health impacts in the hardest-hit areas.
5d
Clinical Trials Arena on MSNSanofi and Regeneron report results from two Phase III trials of COPD treatmentSanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.
Yet thanks to a new hospital-based educational and advocacy initiative for COPD patients, Croswell has been managing well at ...
Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.
In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...
People who lost weight in midlife were less likely to experience heart attacks, strokes, cancer, asthma or chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results